Browsing by Author Joshua, D

0-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
Showing results 1 to 7 of 7
Issue DateTitleAuthor(s)
Jan-2012CD86+ or HLA-G+ can be transferred via trogocytosis from myeloma cells to T cells and are associated with poor prognosisBrown, R; Kabani, K; Favaloro, J; Yang, S; Ho, PJ; Gibson, J; Fromm, P; Suen, H; Woodland, NB; Nassif, N; Hart, D; Joshua, D
2010Characterisation And Relevance Of Cd138-Negative Plasma Cells In Plasma Cell MyelomaReid, S; Yang, S; Brown, R; Kabani, K; Aklilu, E; Ho, P; Woodland, N; Joshua, D
Sep-2015Digital PCR for MRD detection of myelomaMcAuliffe, S; Joshua, D; Brown, R; Catalano, A; Ho, PJ; Nassif, N; Woodland, N; Hart, D; Weatherburn, C; Yang, S; Suen, H; Paul, C; Gibson, J
2013Long-term survival in multiple myeloma is associated with a distinct immunological profile, which includes proliferative cytotoxic T-cell clones and a favourable Treg/Th17 balanceBryant, C; Suen, H; Brown, R; Yang, S; Favaloro, J; Aklilu, E; Gibson, J; Ho, P; Iland, H; Fromm, P; Woodland, N; Nassif, N; Hart, D; Joshua, D
Aug-2016Multiple myeloma causes clonal T-cell immunosenescence: identification of potential novel targets for promoting tumour immunity and implications for checkpoint blockade.Suen, H; Brown, R; Yang, S; Weatherburn, C; Ho, PJ; Woodland, N; Nassif, N; Barbaro, P; Bryant, C; Hart, D; Gibson, J; Joshua, D
Dec-2014Myeloid derived suppressor cells are numerically, functionally and phenotypically different in patients with multiple myeloma.Favaloro, J; Liyadipitiya, T; Brown, R; Yang, S; Suen, H; Woodland, N; Nassif, N; Hart, D; Fromm, P; Weatherburn, C; Gibson, J; Ho, PJ; Joshua, D
Jan-2015Using digital polymerase chain reaction to detect minimal residual disease in myeloma by identifying FGFR3 up-regulation.McAuliffe, S; Brown, R; Catalano, A; Ho, PJ; Nassif, N; Woodland, N; Hart, D; Weatherburn, C; Yang, S; Suen, H; Paul, C; Joshua, D; Gibson, J